Integrin α6 Indicates a Poor Prognosis of Craniopharyngioma through Bioinformatic Analysis and Experimental Validation

Figure 6

Survival analysis according to the levels of CD44, SDC1, PPBP, and ITGA6 expressions. (a) Effects of CD44 expression on craniopharyngioma patient survival. (b) Effects of SDC1 expression on craniopharyngioma patient survival. (c) Effects of PPBP expression on craniopharyngioma patient survival. (d) Effects of ITGA6 expression on craniopharyngioma patient survival.

(a)

(b)

(c)

(d)